Magazine Publishers of America
As the debate on healthcare has evolved, eliminating the deduction for DTC advertising is now actively being considered as a component of the Senate and House plans to fund healthcare reform.
Direct-to-Consumer (DTC) advertising for prescription drugs has been providing important information to patients about disease symptoms and treatment options since the early 1980’s. In recent years, expenditures on prescription drugs have been rising faster than the rate of inflation. Along with the increased expenditures has come a heightened concern that advertising pharmaceuticals directly to consumers may inappropriately increase patient demand for more expensive, brand name drugs.
Key members of the House Energy and Commerce Committee are turning their attention once again to Direct-to-Consumer (DTC) pharmaceutical advertising. Read more
